Hepatic glucose sensing and integrative pathways in the liver (Q38160330)

30 August 2017

title

Hepatic glucose sensing and integrative pathways in the liver (English)

1 reference

30 August 2017

0 references

2

Kristina Schoonjans

0 references

author name string

Maaike H Oosterveer

series ordinal

1

1 reference

30 August 2017

publication date

7 November 2013

1 reference

Cellular and Molecular Life Sciences

30 August 2017

published in

1 reference

30 August 2017

volume

71

1 reference

30 August 2017

issue

8

1 reference

30 August 2017

page(s)

1453-1467

1 reference

Glucose as a regulator of eukaryotic gene transcription

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Hepatocytes: critical for glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Brain, liver, intestine: a triumvirate to coordinate insulin sensitivity of endogenous glucose production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Critical nodes in signalling pathways: insights into insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Physiologic action of glucagon on liver glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Pathways for glucose disposal after meal ingestion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

The SLC2 (GLUT) family of membrane transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Expression of mRNA for glucose transport proteins in jejunum, liver, kidney and skeletal muscle of pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Liver hyperplasia and paradoxical regulation of glycogen metabolism and glucose-sensitive gene expression in GLUT2-null hepatocytes. Further evidence for the existence of a membrane-based glucose release pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Evolution and regulatory role of the hexokinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Time-dependent pseudo-activation of hepatic glycogen synthase b by glucose 6-phosphate without involvement of protein phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Glucose 6-phosphate causes translocation of phosphorylase in hepatocytes and inactivates the enzyme synergistically with glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

The key role of anaplerosis and cataplerosis for citric acid cycle function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Normal hepatic glucose production in the absence of GLUT2 reveals an alternative pathway for glucose release from hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Glucose-induced conformational changes in glucokinase mediate allosteric regulation: transient kinetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Glucokinase and cytosolic phosphoenolpyruvate carboxykinase (GTP) in the human liver. Regulation of gene expression in cultured hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Cloning and characterization of the mouse glucokinase gene locus and identification of distal liver-specific DNase I hypersensitive sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Molecular physiology of mammalian glucokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Transcriptional regulation of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Nuclear receptors and the control of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Minireview: Evolution of NURSA, the Nuclear Receptor Signaling Atlas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Integrated expression profiling and genome-wide analysis of ChREBP targets reveals the dual role for ChREBP in glucose-regulated gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

MondoA, a novel basic helix-loop-helix-leucine zipper transcriptional activator that constitutes a positive branch of a max-like network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

An extended Myc network contributes to glucose homeostasis in cancer and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Mlx, a novel Max-like BHLHZip protein that interacts with the Max network of transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Mlx is the functional heteromeric partner of the carbohydrate response element-binding protein in glucose regulation of lipogenic enzyme genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Direct role of ChREBP.Mlx in regulating hepatic glucose-responsive genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Glucose induces protein targeting to glycogen in hepatocytes by fructose 2,6-bisphosphate-mediated recruitment of MondoA to the promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Evolution of the Max and Mlx networks in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

The C. elegans MDL-1 and MXL-1 proteins can functionally substitute for vertebrate MAD and MAX

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

A novel N-terminal domain may dictate the glucose response of Mondo proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Glucose-dependent transcriptional regulation by an evolutionarily conserved glucose-sensing module

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Mio/dChREBP coordinately increases fat mass by regulating lipid synthesis and feeding behavior in Drosophila.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Mondo/ChREBP-Mlx-regulated transcriptional network is essential for dietary sugar tolerance in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Glucose sensing by MondoA:Mlx complexes: a role for hexokinases and direct regulation of thioredoxin-interacting protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Elevated glucose represses liver glucokinase and induces its regulatory protein to safeguard hepatic phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

LRH-1-dependent glucose sensing determines intermediary metabolism in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Glucose-6-phosphate mediates activation of the carbohydrate responsive binding protein (ChREBP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Fructose 2,6-bisphosphate is essential for glucose-regulated gene transcription of glucose-6-phosphatase and other ChREBP target genes in hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Regulation of nuclear import/export of carbohydrate response element-binding protein (ChREBP): interaction of an alpha-helix of ChREBP with the 14-3-3 proteins and regulation by phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Glucose activates ChREBP by increasing its rate of nuclear entry and relieving repression of its transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Regulation of cellular metabolism by protein lysine acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Mammalian glucokinase and its gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Direct Recruitment of Insulin Receptor and ERK Signaling Cascade to Insulin-Inducible Gene Loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Interrelationship between liver X receptor alpha, sterol regulatory element-binding protein-1c, peroxisome proliferator-activated receptor gamma, and small heterodimer partner in the transcriptional regulation of glucokinase gene expression in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Adenovirus-mediated overexpression of Tcfe3 ameliorates hyperglycaemia in a mouse model of diabetes by upregulating glucokinase in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

The transcription factors HIF-1 and HNF-4 and the coactivator p300 are involved in insulin-regulated glucokinase gene expression via the phosphatidylinositol 3-kinase/protein kinase B pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Activation of glucokinase gene expression by hepatic nuclear factor 4alpha in primary hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

FoxO1 and HNF-4 are involved in regulation of hepatic glucokinase gene expression by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

A key role for orphan nuclear receptor liver receptor homologue-1 in activation of fatty acid synthase promoter by liver X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Genome-wide analysis of hepatic LRH-1 reveals a promoter binding preference and suggests a role in regulating genes of lipid metabolism in concert with FXR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

The nuclear receptor LXR is a glucose sensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Nuclear receptor liver X receptor is O-GlcNAc-modified in response to glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Thyroid hormone receptor beta (TRbeta) and liver X receptor (LXR) regulate carbohydrate-response element-binding protein (ChREBP) expression in a tissue-selective manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Lxralpha deficiency hampers the hepatic adaptive response to fasting in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Protein posttranslational modifications: the chemistry of proteome diversifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Influence of metabolism on epigenetics and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Cracking the O-GlcNAc code in metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Functional lysine modification by an intrinsically reactive primary glycolytic metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Metabolic regulation of epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Metaboloepigenetics: interrelationships between energy metabolism and epigenetic control of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Connecting threads: epigenetics and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Mitochondrial and nucleocytoplasmic isoforms of O-linked GlcNAc transferase encoded by a single mammalian gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Functional expression of O-linked GlcNAc transferase. Domain structure and substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

A lipid-droplet-targeted O-GlcNAcase isoform is a key regulator of the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Mechanism, Structure, and Inhibition of O-GlcNAc Processing Enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

O-GlcNAc processing enzymes: catalytic mechanisms, substrate specificity, and enzyme regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

O-GlcNAc signaling entrains the circadian clock by inhibiting BMAL1/CLOCK ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Glucose sensor O-GlcNAcylation coordinates with phosphorylation to regulate circadian clock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Hepatic glucose sensing via the CREB coactivator CRTC2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

A PGC-1alpha-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

O-GlcNAc regulates FoxO activation in response to glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1α stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Regulation of Akt signaling by O-GlcNAc in euglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Proteome wide purification and identification of O-GlcNAc-modified proteins using click chemistry and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

New nomenclature for chromatin-modifying enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

The Sir2 family of protein deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Cytoplasmic sequestration of HDAC7 from mitochondrial and nuclear compartments upon initiation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

The many faces of insulin-like peptide signalling in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

The fasted/fed mouse metabolic acetylome: N6-acetylation differences suggest acetylation coordinates organ-specific fuel switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Mechanistic insights into the regulation of metabolic enzymes by acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Regulation of glycolysis and gluconeogenesis by acetylation of PKM and PEPCK

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Glucagon-induced acetylation of Foxa2 regulates hepatic lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

ATP-citrate lyase links cellular metabolism to histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Nucleocytosolic acetyl-coenzyme a synthetase is required for histone acetylation and global transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Mitochondrial acetylcarnitine provides acetyl groups for nuclear histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Logic of the yeast metabolic cycle: temporal compartmentalization of cellular processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Coenzyme A and its thioester pools in fasted and fed rat tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Enhanced glucose cycling and suppressed de novo synthesis of glucose-6-phosphate result in a net unchanged hepatic glucose output in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Constitutive hepatic glucokinase activity in db/db and ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Hexosamines, insulin resistance, and the complications of diabetes: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

The metabolically benign and malignant fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Decreased transcription of ChREBP-α/β isoforms in abdominal subcutaneous adipose tissue of obese adolescents with prediabetes or early type 2 diabetes: associations with insulin resistance and hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Glycogen storage disease type Ia: linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Genomic structure of the human glucose 6-phosphate translocase gene and novel mutations in the gene of a Japanese patient with glycogen storage disease type Ib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type Ib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Carbohydrate-response-element-binding protein (ChREBP) and not the liver X receptor α (LXRα) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Acute inhibition of hepatic glucose-6-phosphatase does not affect gluconeogenesis but directs gluconeogenic flux toward glycogen in fasted rats. A pharmacological study with the chlorogenic acid derivative S4048.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Glycogen storage disease, types I to X: criteria for morphologic diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

The role of the lipogenic pathway in the development of hepatic steatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Diabetes mellitus, fasting glucose, and risk of cause-specific death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Cellular metabolism and disease: what do metabolic outliers teach us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

c-Myc is required for the CHREBP-dependent activation of glucose-responsive genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Coactivation of liver receptor homologue-1 by peroxisome proliferator-activated receptor gamma coactivator-1alpha on aromatase promoter II and its inhibition by activated retinoid X receptor suggest a novel target for breast-specific antiestrogen th

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Phosphofructokinase 1 glycosylation regulates cell growth and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

O-GlcNAc signalling: implications for cancer cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

The impact of acetylation and deacetylation on the p53 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Myc-dependent Mitochondrial Generation of Acetyl-CoA Contributes to Fatty Acid Biosynthesis and Histone Acetylation during Cell Cycle Entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Protein kinase A-dependent synergism between GATA factors and the nuclear receptor, liver receptor homolog-1, regulates human aromatase (CYP19) PII promoter activity in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

SUMO-dependent compartmentalization in promyelocytic leukemia protein nuclear bodies prevents the access of LRH-1 to chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

PIASy inhibits LRH-1-dependent CYP11A1 expression by competing for SRC-1 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Functional conservation of interactions between a homeodomain cofactor and a mammalian FTZ-F1 homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Phosphorylation of the hinge domain of the nuclear hormone receptor LRH-1 stimulates transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Repression of the promoter activity mediated by liver receptor homolog-1 through interaction with ku proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Multiprotein bridging factor-1 (MBF-1) is a cofactor for nuclear receptors that regulate lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Molecular mechanism for the potentiation of the transcriptional activity of human liver receptor homolog 1 by steroid receptor coactivator-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Allosteric post-translational modification codes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Lysine acetylation: codified crosstalk with other posttranslational modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1505-Z

Disposition of a mixed meal by the conscious dog

21 January 2018

1 reference

12 December 2020

Short-term control of glucokinase activity: role of a regulatory protein

1 reference

12 December 2020

Hyperlipemia in children with liver glycogen disease

1 reference

12 December 2020

SIRT1 deacetylates and positively regulates the nuclear receptor LXR

1 reference

12 December 2020

Regulation of protein degradation by O-GlcNAcylation: crosstalk with ubiquitination

1 reference

12 December 2020

Localization of the carbohydrate response element of the rat L-type pyruvate kinase gene.

1 reference

12 December 2020

Two CACGTG Motifs with Proper Spacing Dictate the Carbohydrate Regulation of Hepatic Gene Transcription

1 reference

12 December 2020

Corepressor SMRT specifically represses the transcriptional activity of orphan nuclear receptor hB1F/hLRH-1.

1 reference

12 December 2020

Sirtuins as regulators of metabolism and healthspan

1 reference

12 December 2020

Glucose-6-phosphate-mediated activation of liver glycogen synthase plays a key role in hepatic glycogen synthesis.

1 reference

12 December 2020

The disposal of an oral glucose load in healthy subjects. A quantitative study

1 reference

12 December 2020

Modulation of glucokinase expression by hypoxia-inducible factor 1 and upstream stimulatory factor 2 in primary rat hepatocytes

1 reference

12 December 2020

Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans

1 reference

12 December 2020

Acute effects on insulin sensitivity and diurnal metabolic profiles of a high-sucrose compared with a high-starch diet

1 reference

12 December 2020

Glutamine fructose-6-phosphate amidotransferase (GFAT) gene expression and activity in patients with type 2 diabetes: inter-relationships with hyperglycaemia and oxidative stress

1 reference

12 December 2020

The hyperlipidemia in glycogen storage disease

1 reference

12 December 2020

Isolation of the gene for murine glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1A

1 reference

12 December 2020

Glucose 6-Phosphate Produced by Glucokinase, but Not Hexokinase I, Promotes the Activation of Hepatic Glycogen Synthase

1 reference

12 December 2020

The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc.

1 reference

12 December 2020

Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice

1 reference

12 December 2020

Hepatic glucose sensing is required to preserve β cell glucose competence

1 reference

12 December 2020

GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha

1 reference

12 December 2020

ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver

1 reference

12 December 2020

O-GlcNAc cycling: a link between metabolism and chronic disease

1 reference

12 December 2020

Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review)

1 reference

12 December 2020

O-linked N-acetylglucosamine is attached to proteins of the nuclear pore. Evidence for cytoplasmic and nucleoplasmic glycoproteins

1 reference

12 December 2020

Differential Metabolic Effects of Adenovirus-mediated Glucokinase and Hexokinase I Overexpression in Rat Primary Hepatocytes

1 reference

12 December 2020

A two-way street: reciprocal regulation of metabolism and signalling.

1 reference

12 December 2020

Novel insights into ChREBP regulation and function.

1 reference

12 December 2020

Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas

1 reference

12 December 2020

Measurements of electron spin resonance with the pyruvate dehydrogenase complex from Escherichia coli. Studies on the allosteric binding site of acetyl-coenzyme A

1 reference

12 December 2020

Glycogen storage disease type 1 and diabetes: learning by comparing and contrasting the two disorders

1 reference

12 December 2020

Stereospecific transport of glucose in the perfused rat liver

1 reference

12 December 2020

Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver

1 reference

12 December 2020

Ribose 1,5-bisphosphate is a putative regulator of fructose 6-phosphate/fructose 1,6-bisphosphate cycle in liver

1 reference

12 December 2020

Glycogen storage disease type I: pathophysiology of liver adenomas

1 reference

12 December 2020

Activation of phosphofructokinase from rat tissues by 6-phosphogluconate and fructose 2,6-bisphosphate

1 reference

12 December 2020

10.1007/S00018-013-1505-Z

Identifiers

DOI

1 reference

30 August 2017

1 reference